BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3685054)

  • 1. Effects of caffeine and L-phenylisopropyladenosine on locomotor activity of mice.
    Buckholtz NS; Middaugh LD
    Pharmacol Biochem Behav; 1987 Oct; 28(2):179-85. PubMed ID: 3685054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain.
    Hawkins M; Dugich MM; Porter NM; Urbancic M; Radulovacki M
    Brain Res Bull; 1988 Sep; 21(3):479-82. PubMed ID: 3214753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions in the behavioral effects of methylxanthines and adenosine derivatives.
    Katims JJ; Annau Z; Snyder SH
    J Pharmacol Exp Ther; 1983 Oct; 227(1):167-73. PubMed ID: 6194284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)-adenosine (PIA) in mice.
    Ahlijanian MK; Takemori AE
    Life Sci; 1986 Feb; 38(7):577-88. PubMed ID: 3003486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment.
    Johansson B; Georgiev V; Lindström K; Fredholm BB
    Brain Res; 1997 Jul; 762(1-2):153-64. PubMed ID: 9262169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adenosine receptors in caffeine tolerance.
    Holtzman SG; Mante S; Minneman KP
    J Pharmacol Exp Ther; 1991 Jan; 256(1):62-8. PubMed ID: 1846425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine.
    Barraco RA; Coffin VL; Altman HJ; Phillis JW
    Brain Res; 1983 Aug; 272(2):392-5. PubMed ID: 6616215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and electroencephalographic effects of the adenosine1 agonist, L-PIA.
    Martin JV; Berman KF; Skolnick P; Mendelson WB
    Pharmacol Biochem Behav; 1989 Nov; 34(3):507-10. PubMed ID: 2623008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice.
    Ahlijanian MK; Takemori AE
    Eur J Pharmacol; 1985 Jun; 112(2):171-9. PubMed ID: 2992993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adenosine agonist N6-R-phenylisopropyladenosine (R-PIA) stimulates feeding in rats.
    Levine AS; Grace M; Krahn DD; Billington CJ
    Brain Res; 1989 Jan; 477(1-2):280-5. PubMed ID: 2702488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the transport of adenosine, other nucleosides and hypoxanthine in novikoff rat hepatoma cells by methylxanthines, papaverine, N6-cyclohexyladenosine and N6-phenylisopropyladenosine.
    Plagemann PG; Wohlhueter RM
    Biochem Pharmacol; 1984 Jun; 33(11):1783-8. PubMed ID: 6203540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in adenosine receptor sensitivity in morphine-tolerant and -dependent mice.
    Ahlijanian MK; Takemori AE
    J Pharmacol Exp Ther; 1986 Mar; 236(3):615-20. PubMed ID: 3005548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of L-phenylisopropyl adenosine: blockade by caffeine and generalization to 2-chloroadenosine.
    Spencer DG; Lal H
    Life Sci; 1983 May; 32(20):2329-33. PubMed ID: 6302428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
    J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Green RM; Stiles GL
    J Clin Invest; 1986 Jan; 77(1):222-7. PubMed ID: 3003150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat.
    Barraco RA; Aggarwal AK; Phillis JW; Moron MA; Wu PH
    Neurosci Lett; 1984 Jul; 48(2):139-44. PubMed ID: 6483277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherent differences in sensitivity to methylxanthines among inbred mice.
    Logan L; Seale TW; Carney JM
    Pharmacol Biochem Behav; 1986 May; 24(5):1281-6. PubMed ID: 3725830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.
    McNamara RK; Levant B; Taylor B; Ahlbrand R; Liu Y; Sullivan JR; Stanford K; Richtand NM
    Neuroscience; 2006 Nov; 143(1):141-53. PubMed ID: 16938406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of caffeine and L-PIA on rats with selective damage of the hippocampal system.
    Shull RN; Holloway FA
    Pharmacol Biochem Behav; 1985 Mar; 22(3):449-59. PubMed ID: 3991760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.